Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
Abstract:
Embodiments of the invention are directed to methods of diagnosing bacterial infection in a critically ill patient. The methods include obtaining a sample from the patient and determining the patient's level of IL-27 expression. Embodiments of the invention are also directed to methods that include determining both the patient's levels of IL-27 expression and PCT expression and using the combined result to provide a diagnosis of bacterial infection in a critically ill patient.
Information query
Patent Agency Ranking
0/0